LIFE IN THE END ZONE

GlaxoSmithKline (GSK), the fifth largest drug company in the world, just settled with the Department of Justice for a cool $3 billion. It im...

Decreasing the risk of readmission to a hospital is a hot area of research. It has been a target for quality improvement ever since a study ...

A few days ago, the prestigious biomedical journal Nature reported that the water in the Fountain of Youth was contaminated. While the artic...

The rising cost of the Medicare program has suddenly gone from the concern of a handful of Cassandras like the distinguished biomedical ethi...

If you are a man, you have a 1 in 6 chance of developing prostate cancer during your lifetime. The good news is that most men will die with ...

More bad news about dementia in America was released recently by the Alzheimer’s Association in its report, “ Alzheimer’s Facts and Figures ...

“Never Say Die: The Myth and Marketing of the New Old Age,” a new book by Susan Jacoby, is a tour de force. If you can get beyond the strid...

In a rare moment of bipartisanship, Congress unanimously approved the National Alzheimer’s Project Act. The media called it “historic legisl...

The father of modern geriatric medicine, Robert Butler, died last summer at the age of 83. His contributions to the study of aging and to th...

First a seemingly arcane debate at a medical conference about the criteria for diagnosing Alzheimer’s disease made news; then an article in...